SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
48.65    0.95 (1.99%)
Bid:
47.80
Ask:
49.65
Spread: 1.85 (3.87%)
Market Cap: £193.68m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Tender Offer

23 Mar 2010 07:01

23 March 2010

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, INTO ANY

JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS

OF SUCH JURISDICTION CLS Holdings plc ("CLS" or the "Company") Proposed purchase of 1 in every 48 Ordinary Shares of 25p each in the Company ("Ordinary Shares") at 600 pence per share by way of a tender offer (the "Tender Offer") and Notice of General Meeting

On 11 March 2010, the Board of CLS announced in its Annual Report for the year ended 31 December 2009 that the Company intended to purchase 1 in every 42 Ordinary Shares by way of a tender offer at 525p per share. Since then, the Company's average share price has risen such that the Board has determined to amend the ratio and price to 1 in every 48 Ordinary Shares at 600p per share.

CLS is today posting a circular to shareholders in relation to the Tender Offer on the terms set out above. If the maximum number of 1,004,817 Ordinary Shares under the Tender Offer is acquired, this will result in an amount just exceeding £6 million being paid by the Company to participating shareholders.

The Tender Offer is open to all shareholders on the Company's register at 5.00pm on 7 April 2010, who may participate by tendering all or a proportion of their holdings of Ordinary Shares at the above price. No Ordinary Shares will be purchased in relation to the Tender Offer unless the relevant resolution to be proposed at the general meeting of the Company to be held on 8 April 2010 (the 'GM') is passed. The Tender Offer will be void if less than 0.1 per cent. of the issued ordinary share capital of the Company (excluding treasury shares) in aggregate is tendered. The Ordinary Shares purchased under the Tender Offer will be cancelled.

Copies of the Tender Offer circular, tender form and form of proxy will be submitted to the UK Listing Authority, and will shortly be available for inspection at the UK Listing Authority's Document Viewing Facility, which is situated at:

Financial Services Authority25 The North ColonnadeCanary WharfLondon E14 5HSTel No: (0)20 7066 1000

Full details of the Tender Offer are contained in circular which will shortly be available on the CLS website along with the form of proxy at www.clsholdings.com, in the Investor Relations section under Financial Reports. Copies of the documents may also be obtained from the Company Secretary.

Enquiries:CLS Holdings plcDavid FullerTel No: +44 (0)20 7582 7766Kinmont LimitedJonathan GrayTel No: +44 (0)20 7087 9100

Kinmont Limited is advising CLS in relation to the Tender Offer and no one else and will not be responsible to anyone other than CLS for providing the protections afforded to the customers of Kinmont Limited nor for providing any advice in relation to the Tender Offer.

This announcement, which has been issued by the Company and is the sole responsibility of the Company, has been approved only for the purposes of Section 21 of the Financial Services and Markets Act 2000 of the United Kingdom by Kinmont Limited, 5 Clifford Street, London W1S 2LG, a firm which is authorised and regulated in the United Kingdom by the Financial Services Authority.

vendor
Date   Source Headline
6th May 20206:15 pmRNSDirector/PDMR Shareholding
1st May 202012:13 pmRNSDirector/PDMR Shareholding
29th Apr 202011:21 amRNSDisclosure of rights attached to equity shares
23rd Apr 20205:16 pmRNSResult of AGM
23rd Apr 202012:14 pmRNSResult of AGM
23rd Apr 202012:12 pmRNSAppointment of Senior Independent Director
14th Apr 20203:24 pmRNSDirector/PDMR Shareholding
9th Apr 20204:35 pmRNSPrice Monitoring Extension
8th Apr 20207:00 amRNSTrading Statement
6th Apr 20205:36 pmRNSDirector/PDMR Shareholding
1st Apr 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20206:06 pmRNSDirector/PDMR Shareholding
24th Mar 20201:50 pmRNSDirector/PDMR Shareholding
23rd Mar 20204:42 pmRNSAnnual Financial Report
23rd Mar 20203:09 pmRNSDirector/PDMR Shareholding
20th Mar 20205:14 pmRNSDirector/PDMR Shareholding
20th Mar 202010:15 amRNSPrice Monitoring Extension
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Mar 20208:24 amRNSDirector/PDMR Shareholding
12th Mar 20205:22 pmRNSDirector/PDMR Shareholding
10th Mar 20208:53 amRNSDirector/PDMR Shareholding
6th Mar 20205:31 pmRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSFinal Results
24th Feb 20207:00 amRNSNotice of Results
17th Feb 202010:26 amRNSHolding(s) in Company
12th Feb 20202:14 pmRNSDirector/PDMR Shareholding
4th Feb 20206:14 pmRNSNotification of change in a Director's details
23rd Jan 20205:13 pmRNSDirector/PDMR Shareholding
14th Jan 20204:47 pmRNSDirector/PDMR Shareholding
8th Jan 20207:00 amRNSAcquisition
31st Dec 20197:00 amRNSSale of the UK regional office portfolio
11th Dec 20195:16 pmRNSDirector/PDMR Shareholding
21st Nov 20197:00 amRNSTrading Statement
20th Nov 20197:00 amRNSAppointment of independent Non-Executive Director
13th Nov 20197:00 amRNSAcquisition
8th Nov 20194:07 pmRNSDirector/PDMR Shareholding
17th Oct 20194:53 pmRNSDirector/PDMR Shareholding
14th Oct 20197:00 amRNSAcquisition
11th Oct 20195:03 pmRNSDirector/PDMR Shareholding
3rd Oct 20197:00 amRNSAcquisition
6th Sep 20195:41 pmRNSDirector/PDMR Shareholding
3rd Sep 20197:00 amRNSShareholding in Catena AB
2nd Sep 20194:31 pmRNSShareholding in Catena AB
14th Aug 20194:05 pmRNSDirector/PDMR Shareholding
14th Aug 20197:00 amRNSHalf-year Report
8th Aug 20199:09 amRNSDirector/PDMR Shareholding
5th Aug 20195:06 pmRNSNotice of Half Year Results
22nd Jul 20198:03 amRNSCLS announces sales in Munich and Dusseldorf
17th Jul 201911:29 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.